PATENT CLAIM ANALYSIS

Application Number: 15905479
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-03
Patent Classification: ["424", "163100"]

Abstract:
The invention is directed to MtrE peptides and their use in gonorrhea vaccines.

Claim (Index 25):
The vector of  claim 21  wherein the polynucleotide encodes an amino acid sequence of residues 313-467 of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14442832', '10665990', '11605689', '10606618', '10066551']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6966425996459479
- 35 USC 102 Novelty (BERT): 0.4913884774972238
- Combined Prediction Score: 0.6761171874310754
- Mean Citation Score: 167.180714
- Max Citation Score: 230.77364
- Similarity Product: 178.47641495221615

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test